Blog

It's often said that the riskiest stocks can generate the biggest rewards. That isn't a reliable investing mantra, since many high-risk stocks can drop to zero, but many of history's greatest growth

To the frugal value investor, it might seem off that Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) owns shares of cloud-based data company Snowflake (NYSE: SNOW). The stock is

Uber Technologies has traveled along a rocky road since going public in May 2019, generating a lot of headlines but few profits. The business has grown in recent years, providing nearly 7 billion

At the Fool, we love to pick our individual stocks. But there's also a good case to take a basket approach sometimes, buying stocks of several companies within the same industry. After all, one of

Is it possible to find a stock that pays a sustainable yield of 5% or more and has upside potential? It's an elusive combination, but one that can produce total returns that handily beat the market

When cloud data company Snowflake (NYSE: SNOW) went public last month, it captured investors' imaginations with incredible sales growth, well-known backers, and a tremendous first-day rise in stock

Don't let anyone tell you that mid-October is boring. Amazon (NASDAQ: AMZN), Walmart (NYSE: WMT), Target (NYSE: TGT), Best Buy (NYSE: BBY), and Apple (NASDAQ: AAPL) all have big events lined up for

It seems fair to say at this point that the upcoming election is a bit divisive. When looking at stocks, it's helpful to put political persuasions aside and seek out companies that won't get drawn

Airline stocks in recent weeks have been flying through turbulence, caught up in an election-year battle in Washington over a second stimulus bill. The industry has been hit hard by the COVID-19

Luxury jewelry maker Tiffany & Co. has never held a sale in its corporate history. Demand for the company's premium wares and the iconic little blue box has been enough to maintain high prices --

Testing is a major part of conquering the coronavirus crisis. If governments test as many people as possible, those who are sick or carry the virus can self-quarantine, which prevents further spread

If you're ignoring dividend-paying stocks in your investing, you're doing your portfolio a big disservice. Consider, for example, a 2013 J.P. Morgan Asset Management report that looked at companies

Inovio Pharmaceuticals (NASDAQ: INO) seemed like it could make millionaires out of many average investors -- and fast -- earlier this year. The clinical-stage biotech company soared 718% from the

In the bizarre market conditions of 2020, it's become even more evident that Robinhood traders are a cryptic and powerful force. Between their inscrutable support of bankrupt companies and wild

The 2020 news cycle has been dominated by the coronavirus -- and understandably so. There have been over 36 million confirmed cases and 1 million deaths related to the virus worldwide. Economic and

Warren Buffett is one of the most well-known investors of our time, so it pays to heed his advice. And if there's one investment he's a big fan of, it's index funds.

To be fair, Buffett has made

Problems abound for popular pot stock Aurora Cannabis (NYSE: ACB). Poor financial results, an ugly balance sheet, and share dilution problems have chased investors away in 2020. Consequently, Aurora

Of far more importance than a stock's valuation is the business's current size relative to its future potential. And with the COVID-19 pandemic reshaping the economy, lots of smaller companies could

As the coronavirus pandemic has progressed, healthcare companies engaged in the development and manufacturing of COVID-19 vaccines and therapeutics have become the darlings of the stock market

This year has exposed investors to some of the wildest volatility on record. The unprecedented uncertainty created by the coronavirus pandemic caused the benchmark S&P 500 (SNPINDEX: ^GSPC) to lose

When most of us think of coronavirus stocks, we think of vaccine makers or drug treatment companies. A heart-pump specialist doesn't first come to mind. That's why this company wasn't among the most

There's been a lot of focus on clinical stage biotech companies and the coronavirus vaccine race over the past few months. But President Donald Trump's recent COVID-19 diagnosis has thrown one

When it comes to socking money away for retirement, a 401(k) plan isn't your only option -- but it's a worthwhile savings tool to look at. In fact, the more you learn about 401(k)s, the more

Two very different drugmakers have recently joined the elite group of companies with coronavirus vaccines in late-stage testing. Johnson & Johnson (NYSE: JNJ) initiated a global phase 3 clinical

In most investment portfolios, a small number of winning stocks usually account for an outsize share of the overall returns. To get the most out of those winners, investors must resist the urge to